Anti-Complement Factor D Antibody (Lampalizumab)
Catalog No.
F1353
Anti-Complement Factor D Antibody (Lampalizumab)
Featured Products
Lampalizumab (RG 7417) is a humanized monoclonal antibody that targets complement factor D (Factor D) in the complement pathway. Lampalizumab binds to the exosite, sterically blocking factor B from entering the active site. Lampalizumab is used in age-related macular degeneration (AMD) research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
143.8 kDa
Dry ice
1278466-20-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Anti-Factor D, RG7417, 166-32
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P00746
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human Complement Factor D, Fc at 2 ug/mL can bind Anti-Complement Factor D Antibody (Lampalizumab)
Complement Factor D
Please avoid freeze-thaw cycles.